Skip to main content

pharmacology

Pharmacotherapy expertise including drug interactions, dosing optimization, medication safety, and therapeutic decision-making

Zur Installation springen

Quellinformationen

Repository
aizech/halo-core
Letzte Quellaktivität
28. März 2026 um 22:09
Erkannte Sprache von SKILL.md
Englisch
Sterne
2
Forks
1

Installationsoptionen

Standardmäßig ist der Prompt ausgewählt, der zuerst die Quelle prüft. Sie können zu einem direkten Befehl wechseln oder eine lokale Kopie herunterladen.

Quelldateien prüfen

Lesen Sie SKILL.md und alle von SkillsMP angezeigten Begleitdateien, bevor Sie sich für eine Installation entscheiden.

Datei-Explorer
2 Dateien

SKILL.md wird angezeigt

SKILL.md
Quellanweisungen · Schreibgeschützte Vorschau
name
pharmacology
description
Pharmacotherapy expertise including drug interactions, dosing optimization, medication safety, and therapeutic decision-making
metadata
{"version":"1.0.0","author":"HALO Core","tags":["medical","pharmacology","drug-interactions","medication-safety"]}
# Pharmacology Skill Use this skill when evaluating medications, assessing drug interactions, or making pharmacotherapy recommendations. ## When to Use - Reviewing prescription medications - Assessing drug-drug or drug-disease interactions - Dosing recommendations (renal/hepatic impairment) - Therapeutic drug monitoring - Medication reconciliation - Alternative therapy suggestions ## Medication Review Framework ### 1. Indication Assessment - Is each medication appropriately indicated? - Is there evidence-based support for use? - Are there more effective alternatives? ### 2. Dosing Evaluation - Is the dose appropriate for the patient? - Renal function adjustment (creatinine clearance) - Hepatic function consideration - Weight-based dosing where applicable ### 3. Interaction Analysis Check for: - **Contraindicated**: Never use together - **Major**: Significant clinical impact - **Moderate**: May require monitoring - **Minor**: Minimal clinical significance Categories: - Pharmacodynamic (additive/synergistic/antagonistic) - Pharmacokinetic (absorption, distribution, metabolism, excretion) ### 4. Adverse Effects - Common and serious adverse effects - Monitoring parameters - Preventive measures ### 5. Patient Factors Consider: - Age (geriatric/pediatric) - Renal/hepatic function - Pregnancy/lactation - allergies - Comorbidities ## Output Structure ``` Medication Review: [Medication 1] - Indication: [appropriate?] - Dose: [appropriate?] - adjustments needed? - Interactions: [list with severity] - Monitoring: [recommended parameters] Recommendations: 1. [Continue/Modify/Discontinue] - rationale 2. [Add alternative] - rationale 3. [Monitoring plan] ``` ## Common Interaction Categories ### Cardiovascular - QT prolongation combinations - Anticoagulant interactions - Beta-blocker + CYP interactions ### CNS - Sedative combinations - Serotonergic drugs (SSRI, SNRI, triptans) - Anticholinergic burden ### Metabolic - Statin interactions (CYP3A4) - Sulfonylurea interactions - Metformin contraindications ### Anti-infective - Antibiotic interactions - Antifungal/viral interactions - QT prolongation ## Dosing Resources Reference standard dosing guides: - FDA labeling - Lexicomp/Micromedex - UpToDate - Nejm grug information ## Best Practices - Always verify current guidelines - Consider patient-specific factors - Provide alternatives when issues identified - Include monitoring recommendations - Add appropriate disclaimers
Auf GitHub ansehen